Category: Review

Advance in animal model and pharmacological research for diabetic retinopathy

Authors: He Miao,  Pi Rongbiao,  Huang Wenyong DOI: 10.3760/cma.j.issn.2095-0160.2015.01.019 Published 2015-01-10 Cite as Chin J Exp Ophthalmol, 2015,33(1): 87-92. Abstract                              [Download PDF] [Read Full Text] Diabetes mellitus belongs to metabolic disorder. Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus […]

Alteration of cytokine expression in exudative age-related macular degeneration and its targeting therapy

Authors: Gu Xiaoya,  Yu Xiaobing DOI: 10.3760/cma.j.issn.2095-0160.2015.01.020 Published 2015-01-10 Cite as Chin J Exp Ophthalmol, 2015,33(1): 93-96. Abstract                              [Download PDF] [Read Full Text] Exudative age-related macular degeneration (AMD) is the leading cause of central vision loss in elderly population, and its primary […]

Progress in the development of common experimental animal models of the eye neoplasm and the orbital diseases

Authrors: Li Jinru,  Ma Jianmin DOI: 10.3760/cma.j.issn.2095-0160.2015.02.018 Published 2015-02-10 Cite as Chin J Exp Ophthalmol, 2015,33(2): 184-188. Abstract                             [Download PDF] [Read Full Text] The eye neoplasm and the orbital diseases are a class of serious illness which will cause visual function damage and […]

Recent advance research progress on complement factor I and age-related macular degeneration

Auhtors: Wang Qin,  Zhao Haisheng,  Li Li DOI: 10.3760/cma.j.issn.2095-0160.2015.02.019 Published 2015-02-10 Cite as Chin J Exp Ophthalmol, 2015,33(2): 189-192. Abstract                                [Download PDF] [Read Full Text] Age-related macular degeneration (AMD) is one of the most important diseases that cause vision loss among […]

Advances in molecular genetics of glaucoma

Authors: Zhou Xiaomin,  Fan Ning,  Liu Xuyang DOI: 10.3760/cma.j.issn.2095-0160.2015.03.016 Published 2015-03-10 Cite as Chin J Exp Ophthalmol, 2015,33(3): 263-269. Abstract                              [Download PDF] [Read Full Text] Glaucoma is the most common cause of irreversible blindness worldwide.The major performances of glaucoma optic neuropathy are […]

Advances in molecular genetic study on primary angle-closure glaucoma

Authors: Duan Jueni,  Zhang Mingzhi DOI: 10.3760/cma.j.issn.2095-0160.2015.03.017 Published 2015-03-10 Cite as Chin J Exp Ophthalmol, 2015,33(3): 270-274. Abstract                              [Download PDF] [Read Full Text] Primary angle-closure glaucoma (PACG) is a group of complex ophthalmic disorders with genetic heterogeneity.PACG appears to be more frequently […]

Neuroprotective therapy for glaucoma

Authors: Song Wei,  Zhang Chun DOI: 10.3760/cma.j.issn.2095-0160.2015.03.019 Published 2015-03-10 Cite as Chin J Exp Ophthalmol, 2015,33(3): 279-283. Abstract                              [Download PDF] [Read Full Text] Glaucoma is the second leading cause of blindness worldwide.It is mainly caused by glaucomatous optic neuropathy characterized by retinal […]

Current researches in correlation between autophagy and glaucomatous optic neuropathy

Authors: Xu Yupeng,  Xu Xun DOI: 10.3760/cma.j.issn.2095-0160.2015.03.020 Published 2015-03-10 Cite as Chin J Exp Ophthalmol, 2015,33(3): 284-288. Abstract                              [Download PDF] [Read Full Text] Glaucoma is a chronic neurodegenerative disease of optic nerve accompanied by apoptosis of retinal ganglion cells (RGCs), cupping of […]